Salesforce vs. UiPath: Which AI Automation Stock Gives Investors More for Their Money?
Salesforce (CRM) and UiPath (PATH) are compared for AI automation investment. CRM trades at $230, PATH at $13. CRM has 12.8x trailing free cash flow, PATH 18.8x. CRM generated $15.15B, PATH $363M. CRM has more debt, PATH has $1.4B in cash. Hedge funds adjusted positions in Q2 2026.
How this was made
The 30-second read
Why it matters
The analysis offers no new corporate event; likely minimal impact on pricing.
Market read
A comparative piece with limited trading relevance; primarily informational for investors evaluating AI automation stocks.
What to watch
Potential future AI adoption rates and competitive dynamics are not quantified in the article.
Background
A valuation comparison of Salesforce (CRM) and UiPath (PATH) focusing on cash‑flow multiples and balance‑sheet strength.
Ticker impact
The article compares Salesforce's cash‑flow multiple and valuation to UiPath, but provides no new corporate event for Salesforce.
little to no immediate price pressure for Salesforce
No fresh data or catalyst; just a valuation comparison.
The article compares UiPath's cash‑flow multiple and balance‑sheet flexibility to Salesforce, without reporting any new corporate development for UiPath.
little to no immediate price pressure for UiPath
No fresh data or catalyst; just a valuation comparison.
Market effects
Provides a perspective on enterprise AI automation valuation but does not change sector fundamentals.
No regional impact; both companies are US‑listed.
Limited; the piece is a niche comparison rather than a market‑wide driver.
Counterpoint
Investors might view the higher multiple on UiPath as a growth premium rather than a valuation flaw.
Key entities
- companySalesforce, Inc.
US‑listed enterprise‑software provider (ticker CRM).
- companyUiPath, Inc.
US‑listed robotic‑process‑automation firm (ticker PATH).
